Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (181-190 of 663) with videos related to

Pageof 67
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational StudyMatthew A Spinelli, Michael J Peluso, Kara L Lynch, et al.
AIDS Research and Human Retroviruses|August 29, 2012
Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenaseRichard M Dunham, Shari N Gordon, Monica Vaccari, et al.
Journal of Virology|May 1, 2020
Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early InfectionLydia Scharf, Johanna Tauriainen, Marcus Buggert, et al.
Journal of Clinical Microbiology|September 24, 2020
Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral TherapySonia Bakkour, Xutao Deng, Peter Bacchetti, et al.
Ebiomedicine|June 1, 2022
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS eventsSergio Serrano-Villar, Kunling Wu, Peter W Hunt, et al.
AIDS Research and Human Retroviruses|September 9, 2016
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 ViremiaRebecca Nedellec, Joshua T Herbeck, Peter W Hunt, et al.
Atherosclerosis|May 29, 2013
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individualsRushi V Parikh, Rebecca Scherzer, Carl Grunfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cellsHenri-Alexandre Michaud, Devi SenGupta, Miguel de Mulder, et al.
AIDS (London, England)|January 20, 2011
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patientsDaniel A Duprez, Jacqueline Neuhaus, Russell Tracy, et al.
AIDS (London, England)|March 3, 2015
Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32Timothy J Henrich, Emily Hanhauser, Zixin Hu, et al.
Pageof 67

Showing results (181-190 of 663) with videos related to

Sort By:
Pageof 67
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational StudyMatthew A Spinelli, Michael J Peluso, Kara L Lynch, et al.
AIDS Research and Human Retroviruses|August 29, 2012
Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenaseRichard M Dunham, Shari N Gordon, Monica Vaccari, et al.
Journal of Virology|May 1, 2020
Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early InfectionLydia Scharf, Johanna Tauriainen, Marcus Buggert, et al.
Journal of Clinical Microbiology|September 24, 2020
Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral TherapySonia Bakkour, Xutao Deng, Peter Bacchetti, et al.
Ebiomedicine|June 1, 2022
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS eventsSergio Serrano-Villar, Kunling Wu, Peter W Hunt, et al.
AIDS Research and Human Retroviruses|September 9, 2016
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 ViremiaRebecca Nedellec, Joshua T Herbeck, Peter W Hunt, et al.
Atherosclerosis|May 29, 2013
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individualsRushi V Parikh, Rebecca Scherzer, Carl Grunfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cellsHenri-Alexandre Michaud, Devi SenGupta, Miguel de Mulder, et al.
AIDS (London, England)|January 20, 2011
N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patientsDaniel A Duprez, Jacqueline Neuhaus, Russell Tracy, et al.
AIDS (London, England)|March 3, 2015
Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32Timothy J Henrich, Emily Hanhauser, Zixin Hu, et al.
Pageof 67